BioWorld

July 12, 2002

Serono Enlists Marketing Muscle' Of Pfizer In $200M Rebif Alliance

Serono SA is teaming up with Pfizer Inc. to co-promote the multiple sclerosis drug Rebif in the United States, which will position Rebif directly against Biogen Inc.'s powerhouse drug Avonex. (BioWorld Today) Read More

MedImmune Working Feverishly' On Resolving FluMist Concerns

Human Equivalent Of Nematode Dog-1 Implicates Mutated Protein In BRCA1 Breast Cancer Tumors

BioCryst Trims Staff, Changes Focus To Earlier-Stage Programs

Other News To Note

Bioethics Council Votes 10-7 For Therapeutic Cloning Moratorium

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Illustration demonstrating gut-brain axis

CINP 2026: Gut microbiota could predict antidepressant response

BioWorld

The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...

Ascending BCI systems deepen national security, ethical concerns

BioWorld

Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...

Black wavy lines forming an abstract sound wave.png

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

BioWorld

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...